Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/20/1996 | EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
03/20/1996 | EP0701564A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
03/20/1996 | EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host |
03/20/1996 | EP0701450A1 Recombinant viruses and their use in gene therapy |
03/20/1996 | EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein |
03/20/1996 | EP0656070A4 Nucleic acid probes for bacteria of the genus legionella. |
03/20/1996 | EP0635023A4 Covalently cross-linked oligonucleotides. |
03/20/1996 | EP0584343A4 Recombinant calf intestinal alkaline phosphatase |
03/20/1996 | EP0395736B1 Purified thermostable enzyme |
03/20/1996 | EP0355140B1 Human monoclonal anti-hiv-i-antibodies |
03/20/1996 | EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids |
03/20/1996 | CN1119027A Method of controlling insects in plants |
03/20/1996 | CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
03/20/1996 | CN1118983A Tomato spotted wilt virus |
03/19/1996 | US5500483 Pichia pastoris alcohol oxidase ZZA1 regulatory region for heterologous gene expression |
03/19/1996 | US5500411 Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins |
03/19/1996 | US5500370 Thermostable ribonuclease H and genetic constructs therefore |
03/19/1996 | US5500367 Stilbene synthase genes from grapevine |
03/19/1996 | US5500366 Polynucleotide encoding T-cell epitopes of the protein TraT |
03/19/1996 | US5500365 Synthetic plant genes |
03/19/1996 | US5500364 Pure mutants |
03/19/1996 | US5500363 Recombinant thermostable DNA polymerase from archaebacteria |
03/19/1996 | US5500362 Chimeric antibody with specificity to human B cell surface antigen |
03/19/1996 | US5500361 β-ketoacyl-ACP synthetase II genes from plants |
03/19/1996 | US5500360 RNA transformation vector |
03/19/1996 | US5500357 Self-cleavage, ribozymes for different targets linked on same chain |
03/19/1996 | US5500356 Method of nucleic acid sequence selection |
03/19/1996 | US5500355 Used for diagnosis of retroviral diseases |
03/19/1996 | US5500354 Genetic engineering |
03/19/1996 | US5500353 Genetic engineering; caulobacter; vaccines |
03/19/1996 | US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
03/19/1996 | US5500347 Diagnosis of cancerous tumors and determination of their origin |
03/19/1996 | US5500344 Serine protease and uses thereof |
03/19/1996 | US5500341 Nucleotide amplification primers; genetic engineering |
03/19/1996 | CA2002515C Expression enhancer and use thereof to increase the yield in the expression of recombinant genes |
03/17/1996 | CA2158395A1 Coccidiosis poultry vaccine |
03/14/1996 | WO1996007761A2 Method for testing for mutations in dna from a patient sample |
03/14/1996 | WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
03/14/1996 | WO1996007750A1 Methods for calcium phosphate transfection |
03/14/1996 | WO1996007749A2 Methods and compositions for inhibiting production of replication competent virus |
03/14/1996 | WO1996007748A1 Non self-inactivating, expression targeted retroviral vectors |
03/14/1996 | WO1996007747A1 Retroviral vector hybrids and the use thereof for gene transfer |
03/14/1996 | WO1996007746A1 Acetohydroxyacid synthase promoter expression of introduced genes in plants |
03/14/1996 | WO1996007745A2 Mycobacteria functional screening and/or expression vectors |
03/14/1996 | WO1996007744A1 A method of improved production of insulin-like growth factor |
03/14/1996 | WO1996007743A1 Xyloglucan-specific beta-galactosidase |
03/14/1996 | WO1996007742A1 Transgenic plants expressing acc oxidase genes |
03/14/1996 | WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
03/14/1996 | WO1996007740A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
03/14/1996 | WO1996007739A2 Interleukin-1 type 3 receptors |
03/14/1996 | WO1996007738A2 Modified human c3 proteins |
03/14/1996 | WO1996007737A1 A novel haemopoietin receptor |
03/14/1996 | WO1996007736A1 CLONED SstI/SacI RESTRICTION-MODIFICATION SYSTEM |
03/14/1996 | WO1996007735A1 Novel deoxyribonuclease |
03/14/1996 | WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein |
03/14/1996 | WO1996007733A1 Preparation of immortalized cells |
03/14/1996 | WO1996007732A1 Totipotent cells for nuclear transfer |
03/14/1996 | WO1996007728A1 Production and secretion of recombinant fibrinogen by yeast |
03/14/1996 | WO1996007669A1 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
03/14/1996 | WO1996007668A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
03/14/1996 | WO1996007667A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
03/14/1996 | WO1996007664A1 Method of obtaining dna-rich active products |
03/14/1996 | WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
03/14/1996 | WO1996007392A2 Oligonucleotide prodrugs |
03/14/1996 | WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a |
03/14/1996 | WO1996007313A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
03/14/1996 | WO1996006191A3 Primers and probes for the amplification and detection of cmv nucleic acid |
03/14/1996 | WO1996006175A3 Fumonisin-detoxifying enzymes |
03/14/1996 | WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins |
03/14/1996 | WO1996005307A3 17q-linked breast and ovarian cancer susceptibility gene |
03/14/1996 | WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
03/14/1996 | WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
03/14/1996 | WO1996002556A3 Oligonucleotides with anti-mdr-1 gene activity |
03/14/1996 | WO1996001615A3 Hepatitis a virus deletion mutants and vaccine formulations containing the same |
03/14/1996 | WO1996001425A3 Assay for inhibitors of dp-1 and other dp proteins |
03/14/1996 | WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
03/14/1996 | WO1995035373A3 Nucleic acid molecules encoding human contactin |
03/14/1996 | WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
03/14/1996 | WO1995034667A3 Transformation of guar |
03/14/1996 | WO1995034651A3 Corticotropin-releasing factor2 receptors |
03/14/1996 | DE4432053A1 Use of Listeria bacteriophage coded lysine |
03/14/1996 | DE19503952A1 Retrovirale Vektorhybride und deren Verwendung zum Gentransfer Retroviral vector hybrids and their use for gene transfer |
03/14/1996 | CA2199609A1 Interleukin-1 type 3 receptors |
03/14/1996 | CA2199464A1 Oligonucleotide prodrugs |
03/14/1996 | CA2199419A1 Methods and compositions for inhibiting production of replication competent virus |
03/14/1996 | CA2199377A1 Preparation of immortalized cells |
03/14/1996 | CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a |
03/14/1996 | CA2198935A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
03/14/1996 | CA2198928A1 Production and secretion of recombinant fibrinogen by yeast |
03/14/1996 | CA2198870A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
03/14/1996 | CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein |
03/14/1996 | CA2198708A1 Transgenic plants expressing acc oxidase genes |
03/14/1996 | CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
03/14/1996 | CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
03/14/1996 | CA2197888A1 Modified human c3 proteins |
03/14/1996 | CA2197873A1 A novel haemopoietin receptor |
03/14/1996 | CA2197788A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
03/14/1996 | CA2197785A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
03/14/1996 | CA2197479A1 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
03/14/1996 | CA2191233A1 Method for testing for mutations in dna from a patient sample |